Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Finance Home
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
The New Investors
All Markets Summit
Give Feedback
Australia markets closed
ALL ORDS
7,713.10
-32.80
(-0.42%)
AUD/USD
0.6924
+0.0033
(+0.49%)
ASX 200
7,504.10
-34.90
(-0.46%)
OIL
75.37
+1.26
(+1.70%)
GOLD
1,880.40
+0.90
(+0.05%)
BTC-AUD
33,210.47
+10.49
(+0.03%)
✉️ Sign up
Get our best money-saving hacks and pro tips now
Xenon Pharmaceuticals Inc. (XENE)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
39.19
0.00
(0.00%)
At close: 04:00PM EST
40.47
+1.28
(+3.27%)
After hours:
05:01PM EST
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
13,171
18,437
32,166
6,829
Cost of revenue
0
-
-
0
Gross profit
3,500
-
-
6,829
Operating expenses
Research development
92,824
75,463
50,523
38,845
Selling general and administrative
30,997
21,967
12,944
10,803
Total operating expenses
123,821
97,430
63,467
49,648
Operating income or loss
-110,650
-78,993
-31,301
-42,819
Interest expense
-
0
484
1,434
Total other income/expenses net
-7,870
-361
408
282
Income before tax
-114,079
-78,888
-29,094
-41,618
Income tax expense
-537
-6
-257
-23
Income from continuing operations
-113,542
-78,882
-28,837
-41,595
Net income
-113,542
-78,882
-28,837
-41,595
Net income available to common shareholders
-112,635
-77,087
-28,013
-40,027
Basic EPS
-
-1.77
-0.81
-1.54
Diluted EPS
-
-1.77
-0.81
-1.54
Basic average shares
-
43,627
34,542
25,939
Diluted average shares
-
43,627
34,542
25,939
EBITDA
-
-77,982
-27,966
-39,755
© 2023 Yahoo. All rights reserved.
Data disclaimer
Help
Suggestions
Terms
Privacy
Privacy Dashboard
About our ads